Smart nursing cuts kidney damage risk in liver cancer patients

NCT ID NCT07681817

Not yet recruiting Disease control Sponsor: Tianjin Medical University Cancer Institute and Hospital Source: ClinicalTrials.gov ↗

First seen Jul 02, 2026 · Last updated Jul 02, 2026

Summary

This study tests whether a personalized nursing program can prevent acute kidney injury (AKI) in people with liver cancer who undergo interventional therapy. Researchers first use a prediction model to classify patients into low, moderate, or high risk for AKI. Then, they provide targeted nursing care—like hydration support and medication management—based on each patient's risk level. The goal is to see if this proactive approach lowers AKI rates compared to standard care.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: risk-stratified proactive nursing intervention
What this could lead to: If successful, this approach could reduce kidney injury after liver cancer procedures and improve patient recovery.
What could go wrong: This is a single-center study with 200 participants, so results may not apply broadly. The intervention is behavioral, not a drug, so effects may be modest.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LIVER CANCER, ADULT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

hepatocellular carcinoma liver cancer acute kidney injury prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

LIVER CANCER, ADULT

More trials for these conditions

Other studies related to the condition(s) this trial covers.